CYP19A1 and breast cancer: In contrast to premenopausal women, where the primary source of estrogens is ovarian synthesis, postmenopausal women, comprising the majority of breast cancer patients, possess estrogens that are either produced in nonovarian tissues or synthesized peripherally through the human aromatase enzyme [4].